HUTCHMED (China) (HMDCF) Other Non Operating Income (2018 - 2019)
HUTCHMED (China)'s (HMDCF) quarterly Other Non Operating Income came in at $2.0 million in Q4 2019, up 8.74% year-over-year from $1.8 million in Q4 2018, and up 8.74% quarter-over-quarter from $1.8 million in Q4 2018.
Powered by 
Analysis
HUTCHMED (China) (HMDCF) Other Non Operating Income (2018 - 2019) Analysis & Trends
HUTCHMED (China) (HMDCF) has reported Other Non Operating Income for 2 consecutive years, with $2.0 million the latest figure, recorded in Q4 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 212.35 Bn | 198.36 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 181.19 Bn | 178.01 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.48 Bn | 124.62 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.59 Bn | 74.60 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.45 Bn | 56.27 Bn | 1.37 Bn |
| 6 | Moderna | 54.89 Bn | 49.75 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.21 Bn | 30.90 Bn | 992.69 Mn |
| 8 | Biogen | 31.38 Bn | 30.10 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.81 Bn | 29.81 Bn | 1.16 Mn |
| 10 | HUTCHMED (China) | 376.85 Mn | 391.04 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2019 | 1.98 Mn |
| Dec 31, 2018 | 1.82 Mn |
| Sep 30, 2018 | -3.21 Mn |